Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Bionano Genomic (BNGO) Stock Pops on Research Study

By Josh Enomoto, InvestorPlace Contributor

Bionano Genomic is in the news today as a landmark research focusing on genomic mapping technology bolsters BNGO stock.

Why Are Cannabis Stocks TLRY, CGC, CRON Up Today?

By Josh Enomoto, InvestorPlace Contributor

Cannabis stocks are on the move today, finally seeing some green ink on encouraging news. However, the sector remains deeply embattled.

VRAX Stock Alert: Why Is Virax Biolabs Up 120% Today?

By Josh Enomoto, InvestorPlace Contributor

With monkeypox infections rising, Virax Biolabs’ PCR test for the underlying virus is bolstering sentiment for VRAX stock.

Why Are Chip Stocks AMD, NVDA, TSM, ON in the Spotlight Today?

By Josh Enomoto, InvestorPlace Contributor

Though chip stocks are making news amid enthusiasm for the CHIPS Act and recent earnings performances, the narrative is complex.

Tonix Pharmaceuticals (TNXP) Stock Surges 15% on Patent News

By Josh Enomoto, InvestorPlace Contributor

While Tonix Pharmaceuticals has been embattled this year, a critical patent issuance for one of its drugs has bolstered TNXP stock.

Load More